Published:
Last updated:
Publication withdrawn by sponsor
ID
NL-OMON57595
Source
DCRF
Brief title
N.a.
Condition
- Spleen, lymphatic and reticuloendothelial system disorders
Research involving
Human, Data
Sponsors and support
Primary sponsor
:
International PNH Interest Group (IPIG)
Intervention
Outcome measures
Primary outcome
Publication withdrawn by sponsor
Secondary outcome
Publication withdrawn by sponsor
Background summary
Publication withdrawn by sponsor
Study objective
Publication withdrawn by sponsor
Study design
Publication withdrawn by sponsor
Intervention
Publication withdrawn by sponsor
Study burden and risks
Publication withdrawn by sponsor
Trial sites in the Netherlands
N.a.
Listed location countries
Australia, China, Japan, Germany, Spain, Argentina, Switzerland, South Korea, United Kingdom, Canada, France, Greece, Norway, Sweden, Turkey, Taiwan, Belgium, Netherlands, United States
Age
Children (2-11 years)
Adolescents (16-17 years)
Elderly (65 years and older)
Adults (18-64 years)
Adolescents (12-15 years)
Inclusion criteria
Publication withdrawn by sponsor
Exclusion criteria
Publication withdrawn by sponsor
Design
Study phase
:
N/A
Study type
:
Observational non invasive
Intervention model
:
Single
Allocation
:
Non controlled trial
Masking
:
Open (masking not used)
Control
:
Uncontrolled
Primary purpose
:
Other
Recruitment
NL
Recruitment status
:
Recruitment started
Start date (anticipated)
:
Enrollment
:
100
Duration
:
60 months (per patient)
Type
:
Anticipated
WORLD
Recruitment status
:
Recruitment started
Start date (anticipated)
:
Enrollment
:
2000
Type
:
Anticipated
Medical products/devices used
Product type
:
N.a.
IPD sharing statement
Plan to share IPD
:
No
Plan description
N.a.
Positive opinion
Date
:
Application type
:
Amendment
Review commission
:
nWMO adviescommissie MEC-U Nieuwegein
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
ClinicalTrials.gov | NCT06524726 |
DCRF | NWMO24.05.009 |
Research portal | NL-000149 |